
Cititop 1000mg Tablet CR
Marketer
Innovative Pharmaceuticals
Salt Composition
Citicoline (1000mg)
Overview Cititop 1000mg Tablet CR
CerebroGuard 1000mg Extended-Release Tablets are indicated for managing stroke, traumatic brain injury, Alzheimer's disease, and memory impairment associated with Parkinson's disease. This medication safeguards brain neurons from harm and facilitates their repair. CerebroGuard 1000mg Extended-Release Tablets can be administered with or without food, but consistent daily timing is recommended for optimal therapeutic levels. Dosage is individualized based on age and specific condition. Strictly adhere to your physician's prescribed dosage and duration; abrupt cessation may exacerbate symptoms. Potential side effects, such as hypotension, abdominal discomfort, diarrhea, cardiac arrhythmia, skin rash, sleep disturbances, and worsening or onset of paresthesia in affected limbs, are typically transient and self-limiting. Consult your doctor if side effects persist or are bothersome. Prior to commencing treatment, disclose any history of renal impairment, seizures (epilepsy), or current medications. Furthermore, inform your physician of pregnancy, pregnancy plans, or breastfeeding.
Uses of Cititop 1000mg Tablet CR
Managing Stroke|Head Trauma Care|Alzheimer's Disease Management|Dementia in Parkinson's Disease Treatment
Major Benefits of Cititop 1000mg Tablet CR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 1000mg Cititop CR tablet whole; avoid chewing, crushing, or fracturing. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.
Common Side effects of Cititop 1000mg Tablet CR:
- Decreased blood pressure
- Arrhythmia (irregular heartbeats)
- Stomach pain
- Diarrhea
- Insomnia (difficulty in sleeping)
- Rash
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Cititop 1000mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Cititop 1000mg Tablet CR whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, although consistent timing is recommended.
How Cititop 1000mg Tablet CR works:
Neuropathic protection is offered by Cititop 1000mg Controlled-Release Tablets. These tablets support nerve cell health, shielding them from harm and enhancing viability through the synthesis of key neurochemicals such as acetylcholine and phosphatidylcholine. Furthermore, they mitigate the accumulation of free fatty acids at damaged nerve sites.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cititop 1000mg Tablet CR is of uncertain safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Cititop 1000mg controlled-release tablets in pregnancy is currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Cititop 1000mg controlled-release tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
Cititop 1000mg Tablet CR's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Cititop 1000mg CR tablets to individuals with impaired renal function. Dosage modifications for Cititop 1000mg CR tablets may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Cititop 1000mg Tablet CR to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Cititop 1000mg Tablet CR :
Should you forget a Cititop 1000mg Tablet CR dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Cititop 1000mg Tablet CR
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine Nucleoside Diphosphate |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Actions | Cognitive enhancer |
